Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (67)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Drüeke, T. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drüeke, T. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2000) 15: 17-24
© 2000 European Renal Association-European Dialysis and Transplant Association


Toxic Proteins

ß2-Microglobulin and amyloidosis

T. B. Drüeke

INSERM Unit 90 and Department of Nephrology, Hôpital Necker, Paris, France

Abstract

Dialysis-associated amyloidosis is a serious complication in chronic dialysis patients. Its clinical expression in terms of arthralgias, destructive arthopathies and carpal tunnel syndrome is often associated with amyloid deposits, which are mainly composed of ß2-microglobulin (ß2-M) fibrils, but in addition contain a number of other compounds. It is probable that ß2-M-amyloid deposition is related, at least in part, to the elevated plasma ß2-M that is characteristic of chronic renal failure. The latter can decrease with high-performance dialysis techniques but cannot be reduced to the normal range. Almost certainly, several other systemic and local factors are involved, including ß2-M transformed by advanced glycation end products and advanced oxidation protein products, serum P component, ubiquitin, calcium crystals, cytokines, immunoglobulin light chains, proteases and antiproteases, as well as modified collagen and glucosaminoglycans. It is also possible that the ß2-M protein, in its native or modified form, exerts noxious effects on bone and joint tissues, in addition to its mere ‘passive’ presence as amyloid fibrils. Several retrospective studies and one prospective study suggest that dialysis strategies with highly permeable, synthetic membranes and/or ultrapure dialysate may be partially protective or at least delay the onset of dialysis amyloidosis. Successful kidney transplantation generally halts the disease process and leads to rapid relief of osteoarticular pain although regression of ß2-M-amyloid deposits probably does not occur.

Notes

Correspondence and offprint requests to: T. B. Drtüeke, MD, INSERM Unité 90 et Département de Néphrologie, Hôpital Necker, 161 rue de Sèvres, 75743 Paris Cedex 15, France.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
S. Okuno, E. Ishimura, K. Kohno, Y. Fujino-Katoh, Y. Maeno, T. Yamakawa, M. Inaba, and Y. Nishizawa
Serum {beta}2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients
Nephrol. Dial. Transplant., February 1, 2009; 24(2): 571 - 577.
[Abstract] [Full Text] [PDF]


Home page
J Bone Joint Surg BrHome page
W. M. M. Fok and H. B. Leung
Unresolved lytic lesions following parathyroidectomy in a patient with chronic renal failure
J Bone Joint Surg Br, April 1, 2008; 90-B(4): 506 - 509.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. M. Lamas, M. Alonso, F. Sastre, G. Garcia-Trio, J. Saavedra, and L. Palomares
Ultrapure dialysate and inflammatory response in haemodialysis evaluated by darbepoetin requirements--a randomized study
Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2851 - 2858.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Relini, C. Canale, S. De Stefano, R. Rolandi, S. Giorgetti, M. Stoppini, A. Rossi, F. Fogolari, A. Corazza, G. Esposito, et al.
Collagen Plays an Active Role in the Aggregation of beta2-Microglobulin under Physiopathological Conditions of Dialysis-related Amyloidosis
J. Biol. Chem., June 16, 2006; 281(24): 16521 - 16529.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. B. Corlin, J. W. Sen, S. Ladefoged, G. B. Lund, M. H. Nissen, and N. H.H. Heegaard
Quantification of Cleaved {beta}2-Microglobulin in Serum from Patients Undergoing Chronic Hemodialysis
Clin. Chem., July 1, 2005; 51(7): 1177 - 1184.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. Merlini and V. Bellotti
Molecular Mechanisms of Amyloidosis
N. Engl. J. Med., August 7, 2003; 349(6): 583 - 596.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
W. R. Clark and D. Gao
Low-Molecular Weight Proteins in End-Stage Renal Disease: Potential Toxicity and Dialytic Removal Mechanisms
J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S41 - 47.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Chiti, E. De Lorenzi, S. Grossi, P. Mangione, S. Giorgetti, G. Caccialanza, C. M. Dobson, G. Merlini, G. Ramponi, and V. Bellotti
A Partially Structured Species of beta 2-Microglobulin Is Significantly Populated under Physiological Conditions and Involved in Fibrillogenesis
J. Biol. Chem., December 7, 2001; 276(50): 46714 - 46721.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.